Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines

被引:32
作者
Ferrantelli, F [1 ]
Cafaro, A [1 ]
Ensoli, B [1 ]
机构
[1] Ist Super Sanita, AIDS Div, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy
关键词
D O I
10.1016/j.copbio.2004.10.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
By the end of 2004, more than 20 HIV-1 vaccine candidates will have entered clinical testing in at least 30 trials worldwide. Almost half of these vaccines include nonstructural HIV-1 gene products. This represents an important innovation in the HIV vaccine field, because until 9 years ago not even preclinical testing in small animal models had been carried out with such immunogens. This review briefly discusses the experimental evidence that provides the rationale for the use of nonstructural HIV-1 gene products as vaccine antigens, and summarizes the current status and the future development of these novel vaccines.
引用
收藏
页码:543 / 556
页数:14
相关论文
共 101 条
[1]   The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals [J].
Addo, MM ;
Altfeld, M ;
Rosenberg, ES ;
Eldridge, RL ;
Philips, MN ;
Habeeb, K ;
Khatri, A ;
Brander, C ;
Robbins, GK ;
Mazzara, GP ;
Goulder, PJR ;
Walker, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1781-1786
[2]   Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection [J].
Addo, MM ;
Yu, XG ;
Rosenberg, ES ;
Walker, BD ;
Altfeld, M .
DNA AND CELL BIOLOGY, 2002, 21 (09) :671-678
[3]   Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load [J].
Addo, MM ;
Yu, XG ;
Rathod, A ;
Cohen, D ;
Eldridge, RL ;
Strick, D ;
Johnston, MN ;
Corcoran, C ;
Wurcel, AG ;
Fitzpatrick, CA ;
Feeney, ME ;
Rodriguez, WR ;
Basgoz, N ;
Draenert, R ;
Stone, DR ;
Brander, C ;
Goulder, PJR ;
Rosenberg, ES ;
Altfeld, M ;
Walker, BD .
JOURNAL OF VIROLOGY, 2003, 77 (03) :2081-2092
[4]   Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication [J].
Allen, TM ;
Mortara, L ;
Mothé, BR ;
Liebl, M ;
Jing, PC ;
Calore, B ;
Piekarczyk, M ;
Ruddersdorf, R ;
O'Connor, DH ;
Wang, X ;
Wang, CX ;
Allison, DB ;
Altman, JD ;
Sette, A ;
Desrosiers, RC ;
Sutter, G ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4108-4112
[5]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[6]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
VACCINE, 2002, 20 (15) :1949-1955
[7]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[8]   Induction of HIV-1 specific mucosal immune responses by DNA vaccination [J].
Asakura, Y ;
Hinkula, J ;
Leandersson, AC ;
Fukushima, J ;
Okuda, K ;
Wahren, B .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (04) :326-330
[9]  
Asakura Y, 1996, AM J HEMATOL, V53, P116, DOI 10.1002/(SICI)1096-8652(199610)53:2&lt
[10]  
116::AID-AJH9&gt